Upstream Bio, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | — | C | 894,733 | — | — | 894,733 | Oct 15, 2024 |
| Access Industries Holdings LLC | — | C | 1,172,410 | — | — | 5,494,410 | Oct 15, 2024 |
| ORBIMED ADVISORS LLC | — | Purchase | 660,000 | $17.00 | $11,220,000 | 4,554,873 | Oct 15, 2024 |
| Chimovits Erez | — | Purchase | 660,000 | $17.00 | $11,220,000 | 4,554,873 | Oct 15, 2024 |